We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 545

Manhattan Institute issues report on “patent troll” litigation

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 15 2013

With recommendations to reform the legal system to curtail litigation brought by non-practicing entities (NPEs, also referred to as "patent trolls,"

FDA issues guidance on clinical investigations

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 15 2013

The U.S. Food and Drug Administration (FDA) has issued draft guidance intended to enhance human subject protection and the quality of clinical trial

News Bytes - August 29, 2013

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 29 2013

The U.S. Patent and Trademark Office (USPTO) slates its next Software Partnership meeting for October 17, 2013, at the U.C. Berkeley School of Law in

Biosimilar-substitution proposal moves to PA Senate

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 21 2013

The Public Health and Welfare Committee of Pennsylvania's Senate has approved a bill (S.B. 405) that imposes certain requirements on the substitution

Cancer diagnostics company increases IPO goal

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • September 26 2013

Since announcing the terms for its initial public offering (IPO) earlier in September, Foundation Medicine, Inc. has reportedly boosted its goal from

FDA research shows device PAS studies lack sufficient numbers of women

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • January 30 2014

According to a study conducted by researchers with the U.S. Food and Drug Administration's (FDA's) Center for Devices and Radiologic Health

NanoString seeks $55 million to advance breast cancer test

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • January 30 2014

NanoString Technologies, Inc., which develops life-science research tools, including analytical systems used by cancer researchers to study the

Pharma and biotech stocks rise, M&A and IPO values strong, licensing deals

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • September 26 2013

Market analysts commenting on the dramatic rise in the Nasdaq Biotech Index (up 27) and the Dow Jones US Pharma Index (up 21) in the first half of

USDA invests $25 million in bioenergy research

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • January 24 2013

According to Agriculture Secretary Tom Vilsack, the U.S. Department of Agriculture (USDA) has selected four projects that will receive a total of $25

USPTO issues final rule to reflect patent term adjustment revisions

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 22 2014

The U.S. Patent and Trademark Office (USPTO) has issued a final rule to implement revisions to the patent term adjustment provisions under the